Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in Primary Aldosteronism
NCT03174171Phase 2Completed
- Sponsor
- University Hospital Basel
- Start
- May 2017
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in primary aldosteronism (PA), sponsored by University Hospital Basel. Started May 2017; status: completed.
02
Drugs
everolimus
03
Conditions
primary aldosteronism (PA)
Beyond the preview
Go deeper on NCT03174171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03174171.